OPEN-SOURCE SCRIPT
Needle XR
The Didi Index with Full Validation is a technical indicator developed for the TradingView platform, based on the concept of the Didi Index, created by Odir Aguiar (Didi). It uses the relationship between three exponential moving averages (EMAs) of different periods to identify trend reversal or continuation points, known as "needle points." To increase signal reliability, the indicator incorporates validations from four widely used technical indicators: MACD, TRIX, DMI/ADX, and Stochastic. Buy and sell signals are displayed only when all validation conditions are met, ensuring greater accuracy.
The indicator is plotted in a separate panel below the price chart, displaying the Didi Index lines (positive and negative), a central reference line, and clear buy (green triangles) and sell (red triangles) signals.
The indicator is plotted in a separate panel below the price chart, displaying the Didi Index lines (positive and negative), a central reference line, and clear buy (green triangles) and sell (red triangles) signals.
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Open-source script
In true TradingView spirit, the creator of this script has made it open-source, so that traders can review and verify its functionality. Kudos to the author! While you can use it for free, remember that republishing the code is subject to our House Rules.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.